Ȩ > Publication > ±¹ Á¦

16 AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (A  2009.02.206536
15 Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol level  2009.02.206318
14 Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insul  2009.02.207251
13 AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast.  2009.02.206187
12 Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase  2009.02.207306
11 Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.  2009.02.206705
10 Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein ki  2009.02.208201
9 SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen recep  2009.02.206567
8 Pharmacological Stimulation of NADH Oxidation Ameliorates Obesity and Related Phenotypes in Mice.  2009.02.207445
7 Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated recept  2009.02.206534
6 The effect of parental imprinting on the INS-IGF2 locus of Korean type I diabetic patients  2009.02.187319
5 Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.  2009.02.188661
4 Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.  2008.12.258548
3 Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and  2008.12.257317
2 Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell prolifer  2008.12.258473
1 Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-  2008.12.258677
[1][2][3][4] 5 
¸ñ·Ï »õ±Û¾²±â